Ryan Jason
SEC CIK 1585017 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| WGS | GeneDx Holdings Corp. | Executive COB, Dir | 15.5K | $161.4K | $8.33M | 17 | 2022-04-27 | 2026-06-18 |
Most active insiders at WGS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Meister Keith A. | Dir, 10% | $74.03M | — |
| 2 | Casdin Capital, LLC | Dir, 10% | $32.57M | — |
| 3 | Stueland Katherine | CEO, Dir | — | $12.90M |
| 4 | RUCH JOSHUA | Dir | — | $6.09M |
| 5 | Feeley Kevin | CFO | — | $4.07M |
| 6 | Dechairo Bryan | COO | — | $850.6K |
| 7 | Fuchs Thomas | Dir | — | — |
| 8 | Leproust Emily M. | Dir | — | — |
| 9 | Ryan Jason | Dir | — | — |
| 10 | Casdin Eli | Dir, 10% | — | — |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-23 16:31 | 2026-06-18 | WGS | GeneDx Holdings Corp. | Ryan Jason | Dir | M - OptEx | $0.00 | +3,576 | 15.5K | +30% | $0 |
| MI | 2025-08-27 | 2025-08-27 | WGS | GeneDx Holdings Corp. | Ryan Jason | Dir | S - Sale | $127.30 | -38.1K | 103.3K | -27% | -$4.85M |
| 2025-08-27 | 2025-08-27 | WGS | GeneDx Holdings Corp. | Ryan Jason | Dir | S - Sale | $129.65 | -1,150 | 11.9K | -9% | -$149.1K | |
| D | 2025-06-23 | 2025-06-18 | WGS | GeneDx Holdings Corp. | Ryan Jason | Dir | M - OptEx | $0.00 | +12.9K | 13.1K | +9,942% | $0 |
| MI | 2024-11-21 | 2024-11-19+ | WGS | GeneDx Holdings Corp. | Ryan Jason | Dir | S - Sale | $70.57 | -47.0K | 6,129 | -88% | -$3.32M |
| I | 2024-11-21 | 2024-11-19 | WGS | GeneDx Holdings Corp. | Ryan Jason | Dir | G - Gift | $0.00 | -141.4K | 47.0K | -75% | $0 |
| D | 2024-10-17 | 2024-10-15 | WGS | GeneDx Holdings Corp. | Ryan Jason | Dir | M - OptEx | — | +130 | 73.7K | +0.2% | — |
| 2024-01-12 | 2024-01-11 | WGS | GeneDx Holdings Corp. | Ryan Jason | Dir | G - Gift | $0.00 | -73.6K | 0 | -100% | $0 | |
| D | 2024-01-03 | 2023-12-31 | WGS | GeneDx Holdings Corp. | Ryan Jason | Executive COB, Dir | M - OptEx | $0.00 | +67.8K | 73.6K | +1,162% | $0 |
| MI | 2023-11-20 | 2023-11-16+ | WGS | GeneDx Holdings Corp. | Ryan Jason | Executive COB, Dir | P - Purchase | $1.41 | +114.7K | 56.7K | New | +$161.4K |
| 2023-10-18 | 2023-10-17 | WGS | GeneDx Holdings Corp. | Ryan Jason | Executive COB, Dir | S - Sale | $3.19 | -42 | 5,834 | -0.7% | -$133.98 | |
| D | 2023-10-17 | 2023-10-15 | WGS | GeneDx Holdings Corp. | Ryan Jason | Executive COB, Dir | M - OptEx | — | +129 | 5,876 | +2% | — |
| D | 2023-01-04 | 2022-12-31 | WGS | GeneDx Holdings Corp. | Ryan Jason | Executive COB, Dir | M - OptEx | — | +247.5K | 263.4K | +1,563% | — |
| D | 2023-01-04 | 2022-12-31 | WGS | GeneDx Holdings Corp. | Ryan Jason | Executive COB, Dir | S - Sale+OE | $0.26 | -73.7K | 189.6K | -28% | -$19.2K |
| D | 2022-10-18 | 2022-10-17 | WGS | GeneDx Holdings Corp. | Ryan Jason | Executive COB, Dir | S - Sale+OE | $0.86 | -1,281 | 15.8K | -7% | -$1,102 |
| D | 2022-10-18 | 2022-10-15 | WGS | GeneDx Holdings Corp. | Ryan Jason | Executive COB, Dir | M - OptEx | — | +4,278 | 17.1K | +33% | — |
| D | 2022-05-12 | 2022-04-27 | WGS | GeneDx Holdings Corp. | Ryan Jason | Dir | M - OptEx | — | +12.8K | 12.8K | New | — |
Purchase Sale Sale after option exercise All abbreviations